MAPT and Alzheimer disease: As an additional marker of amyloidogenesis, we measured Fyn phosphorylation levels, which have been reported to be hyperphosphorylated in patients with AD [28] and trigger phosphorylation of both APPpTyr682 [27] and tau proteins [35].